SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Deel strikes multi-year deal with Arsenal as tech firm enters global sport

Jensen Huang’s quiet role emerges as Argamani describes Nvidia’s two-year vigil for Avinatan Or

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

Palo Alto Networks: Hamas-linked hackers launch stealth espionage push across Arab governments

Buzz

Most popular

Daily

Weekly

1

Oracle’s stock has fallen 40% since Safra Catz announced her exit. Its latest earnings didn’t calm investors.

2

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

3

After over $390 million in funding, Believer Meats abruptly shuts down

4

Israel’s quantum boom: Startups hit $500 million in funding in 2025

5

BlackRock in talks for major investment in creative-tech firm Artlist

Polypid

6 stories about Polypid

מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Biotech Company Polypid Raises $15 Million

07.11.18|Lilach Baumer

Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body

CTech’s Sunday Roundup of Israeli Tech News

U.S. court charges Israeli CEO with binary options fraud. Stock market downturn leads biotech company Polypid to backtrack on IPO

חיים הורביץ איש עסקים דירקטור ב חברת טבע

Stock Market Downturn Leads Biotech Company Polypid to Backtrack on IPO

25.03.18|Dror Reich

The Israel-based company has postponed its planned IPO after Nasdaq, Dow Jones trended down heavily last week

אלביט מערכות נתנאל גרופ פארק תמר רחובות

CTech’s Thursday Israeli Tech News Roundup

Israel-based defense and homeland security manufacturer and contractor Elbit wins a $65 million contract with an unnamed Asian-Pacific country. In protest of new bonus plan, Teva sued by Israeli employees

נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Polypid Aims to Raise $75 Million with Nasdaq IPO

15.03.18|Dror Reich

The Israel-based company develops a pharmaceutical mechanism that slows down drug delivery

Controlled Drug Release Company Polypid Attempts Second Nasdaq IPO

11.02.18|Dror Reich

The Israel-based company is looking to raise up to $86.25 million to fund clinical development and trials and manufacturing activities